Michael Sailer Selected Research

Michael Sailer Research Topics

7	Multiple Sclerosis 10/2019 - 07/2004
3	Stroke (Strokes) 02/2024 - 01/2014
1	Myocarditis (Carditis) 03/2024
1	Tricuspid Valve Insufficiency (Insufficiency, Tricuspid Valve) 03/2024
1	Peripheral Vascular Diseases (Peripheral Vascular Disease) 02/2024
1	Atrial Fibrillation 02/2024
1	Hemianopsia (Bitemporal Hemianopsia) 01/2021
1	Disease Progression 06/2019
1	Aphasia (Dysphasia) 01/2014
1	Lymphoma (Lymphomas) 11/2012
1	Necrosis 07/2011
1	Autoimmune Hepatitis 06/2007
1	Neoplasms (Cancer) 08/2006
1	Glioblastoma (Glioblastoma Multiforme) 08/2006

2	Protein Isoforms (Isoforms)IBA 08/2006 - 07/2004
2	Transforming Growth Factor beta (TGF-beta)IBA 08/2006 - 07/2004
1	AnticoagulantsIBA 02/2024
1	salicylhydroxamic acid (SHAM)IBA 01/2021
1	polyetheretherketoneIBA 06/2019
1	Biomarkers (Surrogate Marker)IBA 01/2019
1	Natalizumab (Tysabri)FDA Link 11/2012
1	Mitoxantrone (Novantrone)FDA LinkGeneric 01/2012
1	Interferon beta-1a FDA Link 01/2012
1	InterferonsIBA 01/2012
1	Nerve Growth Factors (Neurotrophins)IBA 07/2011
1	Ciliary Neurotrophic Factor (CNTF)IBA 07/2011
1	Nitric Oxide Synthase Type II (Inducible Nitric Oxide Synthase)IBA 07/2011
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 07/2011
1	Methylprednisolone FDA LinkGeneric 07/2011
1	GlucocorticoidsIBA 07/2011
1	Adrenal Cortex Hormones (Corticosteroids)IBA 07/2011
1	Glatiramer Acetate (Copaxone)FDA Link 06/2007
1	Transforming Growth Factor beta1 (TGF beta 1)IBA 08/2006
1	Transforming Growth Factor beta2IBA 08/2006
1	CytokinesIBA 08/2006
1	Intravenous Immunoglobulins (IVIG)FDA Link 07/2004

3	Therapeutics 01/2014 - 05/2010
1	Cardiac Resynchronization Therapy 03/2024
1	Heart-Assist Devices 03/2024
1	Neurological Rehabilitation 10/2019
1	Aftercare (After-Treatment) 07/2004